Overcoming Drug Resistance: Precision Medicine Drug Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Drug Development".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 40
Special Issue Editors
2. Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, 200 First Street SW, Rochester, MN 55905, USA
3. School of Public Health, University of Minnesota-Twin Cities, 420 Delaware St SE, Minneapolis, MN 55455, USA
Interests: evidence based medicine; translational medical research; clinical studies of novel medication
Special Issues, Collections and Topics in MDPI journals
Interests: gastroenterology; cancer immunology; gene therapy
Special Issues, Collections and Topics in MDPI journals
Interests: internal medicine
Special Issue Information
Dear Colleagues,
Drug resistance remains one of the greatest challenges in modern oncology. Despite significant advances in treatments, such as targeted therapies and immunotherapies, many patients still experience relapse due to intrinsic or acquired resistance to treatment. As the field of precision medicine continues to evolve, there is an increasing need to search and develop innovative strategies to overcome resistance and improve patient outcomes.
This Special Issue of Cancers aims to highlight recent progress in understanding the molecular and cellular mechanisms of drug resistance, and how precision medicine approaches—such as biomarker-guided therapies, genomic profiling, combination treatments, and novel drug delivery systems—can be leveraged to overcome these challenges. We also welcome studies grounded in evidence-based medicine, including clinical trials, real-world data analyses, systematic reviews, and meta-analyses, which not only support the translation of precision strategies into practice but also provide critical evidence and guidance for clinical decision-making. Furthermore, this Special Issue encourages research on how precision medicine drug therapies can help prevent cancer relapse and reduce treatment-related complications.
By bringing together contributions from diverse disciplines, this Special Issue aims to deepen our understanding of drug resistance in both solid tumors and hematologic malignancies, and to advance the development of more effective, personalized cancer therapies.
Dr. Chenyu Sun
Dr. Yuting Huang
Dr. Raveena Manem
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug resistance
- precision medicine
- molecular and cellular mechanisms
- biomarker-guided therapy
- genomic profiling
- combination treatment
- novel drug delivery system
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
